SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007133
Filing Date
2024-05-08
Accepted
2024-05-07 19:03:52
Documents
104
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cyrx-20240331x10q.htm   iXBRL 10-Q 2078069
2 EX-31.1 cyrx-20240331xex31d1.htm EX-31.1 14261
3 EX-31.2 cyrx-20240331xex31d2.htm EX-31.2 13147
4 EX-32.1 cyrx-20240331xex32d1.htm EX-32.1 17244
5 GRAPHIC cyrx-20240331x10q004.jpg GRAPHIC 8177
  Complete submission text file 0001558370-24-007133.txt   10950602

Data Files

Seq Description Document Type Size
6 EX-101.SCH cyrx-20240331.xsd EX-101.SCH 72100
7 EX-101.CAL cyrx-20240331_cal.xml EX-101.CAL 96996
8 EX-101.DEF cyrx-20240331_def.xml EX-101.DEF 293216
9 EX-101.LAB cyrx-20240331_lab.xml EX-101.LAB 654568
10 EX-101.PRE cyrx-20240331_pre.xml EX-101.PRE 516267
108 EXTRACTED XBRL INSTANCE DOCUMENT cyrx-20240331x10q_htm.xml XML 2199767
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

IRS No.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34632 | Film No.: 24923732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)